A new model known as BoltzGen designs protein binders for any biological target from scratch. Developed at MIT, BoltzGen has shown promise for hard-to-treat targets in cancer and neurodegenerative diseases.
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases